Amyloid tumour.
- Published in:
- 2010
- By:
- Publication type:
- Other
Works matching IS 00071048 AND DT 2010 AND VI 150 AND IP 4
Results: 20
1
2
Plasma cell leukaemia and other aggressive plasma cell malignancies.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 418, doi. 10.1111/j.1365-2141.2010.08157.x
- By:
- Publication type:
- Article
3
Age-related complications in treatment-naïve patients with thalassaemia intermedia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
4
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
5
Paroxysmal nocturnal haemoglobinuria clones in children with acquired aplastic anaemia: a prospective single centre study.
- Published in:
- 2010
- By:
- Publication type:
- Letter
6
Imaging findings in relapsing multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- Other
7
New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores.
- Published in:
- 2010
- By:
- Publication type:
- Letter
8
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study.
- Published in:
- 2010
- By:
- Publication type:
- Letter
9
The myths about platelet transfusions in immune-mediated thrombocytopenias.
- Published in:
- 2010
- By:
- Publication type:
- Letter
10
A severe case of warfarin–canrenoate interaction: a role for genetic predisposition?
- Published in:
- 2010
- By:
- Publication type:
- Letter
11
New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron stores. Response to Kontoghiorghes et al.
- Published in:
- 2010
- By:
- Publication type:
- Letter
12
Thromboembolic events are not uncommon in patients with immune thrombocytopenia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
13
Prognostic factors in adult acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 389, doi. 10.1111/j.1365-2141.2010.08246.x
- By:
- Publication type:
- Article
14
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 428, doi. 10.1111/j.1365-2141.2010.08264.x
- By:
- Publication type:
- Article
15
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 438, doi. 10.1111/j.1365-2141.2010.08265.x
- By:
- Publication type:
- Article
16
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 446, doi. 10.1111/j.1365-2141.2010.08266.x
- By:
- Publication type:
- Article
17
Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 456, doi. 10.1111/j.1365-2141.2010.08267.x
- By:
- Publication type:
- Article
18
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 473, doi. 10.1111/j.1365-2141.2010.08270.x
- By:
- Publication type:
- Article
19
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 406, doi. 10.1111/j.1365-2141.2010.08283.x
- By:
- Publication type:
- Article
20
Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expression.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 463, doi. 10.1111/j.1365-2141.2010.08285.x
- By:
- Publication type:
- Article